注意欠陥・多動性障害（ADHD）の世界市場（～2026年）

• 英文タイトル：Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY10920 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は注意欠陥・多動性障害（ADHD）のグローバル市場について調査・分析したレポートです。種類別（覚醒剤、非覚醒剤）市場規模、用途別（専門クリニック、病院、小売）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別注意欠陥・多動性障害（ADHD）の競争状況、市場シェア ・世界の注意欠陥・多動性障害（ADHD）市場：種類別市場規模 2015年-2020年（覚醒剤、非覚醒剤） ・世界の注意欠陥・多動性障害（ADHD）市場：種類別市場規模予測 2021年-2026年（覚醒剤、非覚醒剤） ・世界の注意欠陥・多動性障害（ADHD）市場：用途別市場規模 2015年-2020年（専門クリニック、病院、小売） ・世界の注意欠陥・多動性障害（ADHD）市場：用途別市場規模予測 2021年-2026年（専門クリニック、病院、小売） ・北米の注意欠陥・多動性障害（ADHD）市場分析：米国、カナダ ・ヨーロッパの注意欠陥・多動性障害（ADHD）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの注意欠陥・多動性障害（ADHD）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の注意欠陥・多動性障害（ADHD）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの注意欠陥・多動性障害（ADHD）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Takeda、Neos Therapeutics、Eli Lilly、Pfizer、Alcobra、Supernus Pharmaceuticals、Noven Pharmaceuticals、Novartis、Johnson & Johnson、Curemark ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Attention Deficit Hyperactivity Disorder (ADHD) is a brain disorder marked by an ongoing pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development. It may begin in early childhood and can continue into adulthood. Without treatment, ADHD can cause problems at home, at school, at work, and with relationships. In the past, ADHD was termed as Attention Deficit Disorder (ADD). The exact cause is not known, but ADHD tends to run in families. Boys are about three times more likely than girls to be diagnosed with it.
For many people, ADHD medications reduce hyperactivity and impulsivity and improve their ability to focus, work, and learn. On the basis of medication the market size covers Stimulants (Amphetamine, Methylphenidate, Dextroamphetamine, Dexmethylphenidate, and Lisdexamfetamine Dimesylate): Stimulant is the most common type of medication used for treating ADHD. It increases the brain chemicals dopamine and norepinephrine, which play important roles in thinking and attention; Non-stimulants (Atomoxetine, Bupropion, Guanfacine, and Clonidine): These medications take longer to start working than stimulants, but can also improve focus, attention, and impulsivity in a person with ADHD. Although not approved by the U.S. Food and Drug Administration (FDA) specifically for the treatment of ADHD, some antidepressants are sometimes used alone or in combination with a stimulant to treat ADHD.

Market Analysis and Insights: Global Attention Deficit Hyperactivity Disorder (ADHD) Market
The global Attention Deficit Hyperactivity Disorder (ADHD) market size is projected to reach US$ 14890 million by 2026, from US$ 14330 million in 2020, at a CAGR of 3.6%% during 2021-2026.

Global Attention Deficit Hyperactivity Disorder (ADHD) Scope and Market Size
Attention Deficit Hyperactivity Disorder (ADHD) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Attention Deficit Hyperactivity Disorder (ADHD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Takeda
Neos Therapeutics
Eli Lilly
Pfizer
Alcobra
Supernus Pharmaceuticals
Noven Pharmaceuticals
Novartis
Johnson & Johnson
Curemark

Market segment by Type, the product can be split into
Stimulants
Non-Stimulants
Market segment by Application, split into
Specialty Clinics
Hospital
Retail

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Attention Deficit Hyperactivity Disorder (ADHD) Revenue
1.4 Market by Type
1.4.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Stimulants
1.4.3 Non-Stimulants
1.5 Market by Application
1.5.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Application: 2020 VS 2026
1.5.2 Specialty Clinics
1.5.3 Hospital
1.5.4 Retail
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Perspective (2015-2026)
2.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Growth Trends by Regions
2.2.1 Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Attention Deficit Hyperactivity Disorder (ADHD) Historic Market Share by Regions (2015-2020)
2.2.3 Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Strategy
2.3.6 Primary Interviews with Key Attention Deficit Hyperactivity Disorder (ADHD) Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Attention Deficit Hyperactivity Disorder (ADHD) Players by Market Size
3.1.1 Global Top Attention Deficit Hyperactivity Disorder (ADHD) Players by Revenue (2015-2020)
3.1.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Players (2015-2020)
3.1.3 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Concentration Ratio
3.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Attention Deficit Hyperactivity Disorder (ADHD) Revenue in 2019
3.3 Attention Deficit Hyperactivity Disorder (ADHD) Key Players Head office and Area Served
3.4 Key Players Attention Deficit Hyperactivity Disorder (ADHD) Product Solution and Service
3.5 Date of Enter into Attention Deficit Hyperactivity Disorder (ADHD) Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Historic Market Size by Type (2015-2020)
4.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Application (2015-2020)
5.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2015-2020)
6.2 Attention Deficit Hyperactivity Disorder (ADHD) Key Players in North America (2019-2020)
6.3 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2015-2020)
6.4 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Application (2015-2020)

7 Europe
7.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2015-2020)
7.2 Attention Deficit Hyperactivity Disorder (ADHD) Key Players in Europe (2019-2020)
7.3 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2015-2020)
7.4 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Application (2015-2020)

8 China
8.1 China Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2015-2020)
8.2 Attention Deficit Hyperactivity Disorder (ADHD) Key Players in China (2019-2020)
8.3 China Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2015-2020)
8.4 China Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Application (2015-2020)

9 Japan
9.1 Japan Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2015-2020)
9.2 Attention Deficit Hyperactivity Disorder (ADHD) Key Players in Japan (2019-2020)
9.3 Japan Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2015-2020)
9.4 Japan Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2015-2020)
10.2 Attention Deficit Hyperactivity Disorder (ADHD) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2015-2020)
10.4 Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Application (2015-2020)

11 India
11.1 India Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2015-2020)
11.2 Attention Deficit Hyperactivity Disorder (ADHD) Key Players in India (2019-2020)
11.3 India Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2015-2020)
11.4 India Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2015-2020)
12.2 Attention Deficit Hyperactivity Disorder (ADHD) Key Players in Central & South America (2019-2020)
12.3 Central & South America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2015-2020)
12.4 Central & South America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Takeda
13.1.1 Takeda Company Details
13.1.2 Takeda Business Overview
13.1.3 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Introduction
13.1.4 Takeda Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2015-2020))
13.1.5 Takeda Recent Development
13.2 Neos Therapeutics
13.2.1 Neos Therapeutics Company Details
13.2.2 Neos Therapeutics Business Overview
13.2.3 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Introduction
13.2.4 Neos Therapeutics Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2015-2020)
13.2.5 Neos Therapeutics Recent Development
13.3 Eli Lilly
13.3.1 Eli Lilly Company Details
13.3.2 Eli Lilly Business Overview
13.3.3 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Introduction
13.3.4 Eli Lilly Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2015-2020)
13.3.5 Eli Lilly Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview
13.4.3 Pfizer Attention Deficit Hyperactivity Disorder (ADHD) Introduction
13.4.4 Pfizer Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2015-2020)
13.4.5 Pfizer Recent Development
13.5 Alcobra
13.5.1 Alcobra Company Details
13.5.2 Alcobra Business Overview
13.5.3 Alcobra Attention Deficit Hyperactivity Disorder (ADHD) Introduction
13.5.4 Alcobra Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2015-2020)
13.5.5 Alcobra Recent Development
13.6 Supernus Pharmaceuticals
13.6.1 Supernus Pharmaceuticals Company Details
13.6.2 Supernus Pharmaceuticals Business Overview
13.6.3 Supernus Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Introduction
13.6.4 Supernus Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2015-2020)
13.6.5 Supernus Pharmaceuticals Recent Development
13.7 Noven Pharmaceuticals
13.7.1 Noven Pharmaceuticals Company Details
13.7.2 Noven Pharmaceuticals Business Overview
13.7.3 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Introduction
13.7.4 Noven Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2015-2020)
13.7.5 Noven Pharmaceuticals Recent Development
13.8 Novartis
13.8.1 Novartis Company Details
13.8.2 Novartis Business Overview
13.8.3 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Introduction
13.8.4 Novartis Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2015-2020)
13.8.5 Novartis Recent Development
13.9 Johnson & Johnson
13.9.1 Johnson & Johnson Company Details
13.9.2 Johnson & Johnson Business Overview
13.9.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Introduction
13.9.4 Johnson & Johnson Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2015-2020)
13.9.5 Johnson & Johnson Recent Development
13.10 Curemark
13.10.1 Curemark Company Details
13.10.2 Curemark Business Overview
13.10.3 Curemark Attention Deficit Hyperactivity Disorder (ADHD) Introduction
13.10.4 Curemark Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2015-2020)
13.10.5 Curemark Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Attention Deficit Hyperactivity Disorder (ADHD) Key Market Segments
Table 2. Key Players Covered: Ranking by Attention Deficit Hyperactivity Disorder (ADHD) Revenue
Table 3. Ranking of Global Top Attention Deficit Hyperactivity Disorder (ADHD) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Stimulants
Table 6. Key Players of Non-Stimulants
Table 7. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Regions (2015-2020)
Table 11. Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Strategy
Table 17. Main Points Interviewed from Key Attention Deficit Hyperactivity Disorder (ADHD) Players
Table 18. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Players (2015-2020) (Million US$)
Table 19. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Players (2015-2020)
Table 20. Global Top Attention Deficit Hyperactivity Disorder (ADHD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Attention Deficit Hyperactivity Disorder (ADHD) as of 2019)
Table 21. Global Attention Deficit Hyperactivity Disorder (ADHD) by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Attention Deficit Hyperactivity Disorder (ADHD) Product Solution and Service
Table 24. Date of Enter into Attention Deficit Hyperactivity Disorder (ADHD) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2015-2020) (Million US$)
Table 27. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Share by Type (2015-2020)
Table 28. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Type (2021-2026)
Table 29. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Share by Application (2015-2020)
Table 30. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Application (2015-2020) (Million US$)
Table 31. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Share by Application (2021-2026)
Table 32. North America Key Players Attention Deficit Hyperactivity Disorder (ADHD) Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Attention Deficit Hyperactivity Disorder (ADHD) Market Share (2019-2020)
Table 34. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2015-2020) (Million US$)
Table 35. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type (2015-2020)
Table 36. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Application (2015-2020) (Million US$)
Table 37. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Application (2015-2020)
Table 38. Europe Key Players Attention Deficit Hyperactivity Disorder (ADHD) Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Attention Deficit Hyperactivity Disorder (ADHD) Market Share (2019-2020)
Table 40. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type (2015-2020)
Table 42. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Application (2015-2020)
Table 44. China Key Players Attention Deficit Hyperactivity Disorder (ADHD) Revenue (2019-2020) (Million US$)
Table 45. China Key Players Attention Deficit Hyperactivity Disorder (ADHD) Market Share (2019-2020)
Table 46. China Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2015-2020) (Million US$)
Table 47. China Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type (2015-2020)
Table 48. China Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Application (2015-2020) (Million US$)
Table 49. China Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Application (2015-2020)
Table 50. Japan Key Players Attention Deficit Hyperactivity Disorder (ADHD) Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Attention Deficit Hyperactivity Disorder (ADHD) Market Share (2019-2020)
Table 52. Japan Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type (2015-2020)
Table 54. Japan Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Attention Deficit Hyperactivity Disorder (ADHD) Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Attention Deficit Hyperactivity Disorder (ADHD) Market Share (2019-2020)
Table 58. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type (2015-2020)
Table 60. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Application (2015-2020)
Table 62. India Key Players Attention Deficit Hyperactivity Disorder (ADHD) Revenue (2019-2020) (Million US$)
Table 63. India Key Players Attention Deficit Hyperactivity Disorder (ADHD) Market Share (2019-2020)
Table 64. India Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2015-2020) (Million US$)
Table 65. India Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type (2015-2020)
Table 66. India Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Application (2015-2020) (Million US$)
Table 67. India Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Attention Deficit Hyperactivity Disorder (ADHD) Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Attention Deficit Hyperactivity Disorder (ADHD) Market Share (2019-2020)
Table 70. Central & South America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type (2015-2020)
Table 72. Central & South America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Application (2015-2020)
Table 74. Takeda Company Details
Table 75. Takeda Business Overview
Table 76. Takeda Product
Table 77. Takeda Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2015-2020) (Million US$)
Table 78. Takeda Recent Development
Table 79. Neos Therapeutics Company Details
Table 80. Neos Therapeutics Business Overview
Table 81. Neos Therapeutics Product
Table 82. Neos Therapeutics Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2015-2020) (Million US$)
Table 83. Neos Therapeutics Recent Development
Table 84. Eli Lilly Company Details
Table 85. Eli Lilly Business Overview
Table 86. Eli Lilly Product
Table 87. Eli Lilly Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2015-2020) (Million US$)
Table 88. Eli Lilly Recent Development
Table 89. Pfizer Company Details
Table 90. Pfizer Business Overview
Table 91. Pfizer Product
Table 92. Pfizer Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2015-2020) (Million US$)
Table 93. Pfizer Recent Development
Table 94. Alcobra Company Details
Table 95. Alcobra Business Overview
Table 96. Alcobra Product
Table 97. Alcobra Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2015-2020) (Million US$)
Table 98. Alcobra Recent Development
Table 99. Supernus Pharmaceuticals Company Details
Table 100. Supernus Pharmaceuticals Business Overview
Table 101. Supernus Pharmaceuticals Product
Table 102. Supernus Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2015-2020) (Million US$)
Table 103. Supernus Pharmaceuticals Recent Development
Table 104. Noven Pharmaceuticals Company Details
Table 105. Noven Pharmaceuticals Business Overview
Table 106. Noven Pharmaceuticals Product
Table 107. Noven Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2015-2020) (Million US$)
Table 108. Noven Pharmaceuticals Recent Development
Table 109. Novartis Business Overview
Table 110. Novartis Product
Table 111. Novartis Company Details
Table 112. Novartis Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2015-2020) (Million US$)
Table 113. Novartis Recent Development
Table 114. Johnson & Johnson Company Details
Table 115. Johnson & Johnson Business Overview
Table 116. Johnson & Johnson Product
Table 117. Johnson & Johnson Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2015-2020) (Million US$)
Table 118. Johnson & Johnson Recent Development
Table 119. Curemark Company Details
Table 120. Curemark Business Overview
Table 121. Curemark Product
Table 122. Curemark Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2015-2020) (Million US$)
Table 123. Curemark Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type: 2020 VS 2026
Figure 2. Stimulants Features
Figure 3. Non-Stimulants Features
Figure 4. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Application: 2020 VS 2026
Figure 5. Specialty Clinics Case Studies
Figure 6. Hospital Case Studies
Figure 7. Retail Case Studies
Figure 8. Attention Deficit Hyperactivity Disorder (ADHD) Report Years Considered
Figure 9. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Regions: 2020 VS 2026
Figure 11. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Players in 2019
Figure 14. Global Top Attention Deficit Hyperactivity Disorder (ADHD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Attention Deficit Hyperactivity Disorder (ADHD) as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Attention Deficit Hyperactivity Disorder (ADHD) Revenue in 2019
Figure 16. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed

---